TTK Healthcare Ltd.
BSE: 507747 | Sector: Health care |
NSE: TTKHLTCARE | ISIN Code: INE910C01018 |
BSE 00:00 | 15 Jan | 568.45 |
-8.55 (-1.48%) |
OPEN
570.00 |
HIGH
570.00 |
LOW
568.45 |
NSE 00:00 | 15 Jan | 564.10 |
-14.55 (-2.51%) |
OPEN
582.05 |
HIGH
582.05 |
LOW
560.00 |
OPEN | 570.00 |
PREVIOUS CLOSE | 577.00 |
VOLUME | 4 |
52-Week high | 629.00 |
52-Week low | 262.05 |
P/E | 31.86 |
Mkt Cap.(Rs cr) | 803 |
Buy Price | 552.00 |
Buy Qty | 1.00 |
Sell Price | 629.00 |
Sell Qty | 1.00 |
TTK Healthcare Ltd. (TTKHLTCARE) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Sun Pharma.Inds. | 604.00 | -3.05 | -0.50 | 3211.14 |
Dr Reddy's Labs | 5207.60 | -102.35 | -1.93 | 2937.70 |
Cipla | 823.55 | -16.95 | -2.02 | 2318.17 |
Aurobindo Pharma | 936.30 | -22.85 | -2.38 | 1872.74 |
Cadila Health. | 488.00 | -15.30 | -3.04 | 1412.90 |
Divi's Lab. | 3642.70 | -82.45 | -2.21 | 1372.71 |
Glenmark Pharma. | 512.25 | -8.20 | -1.58 | 1354.55 |
Alkem Lab | 3102.80 | -10.35 | -0.33 | 1264.42 |
Alembic Pharma | 1087.90 | -3.45 | -0.32 | 969.40 |
Torrent Pharma. | 2713.35 | -75.85 | -2.72 | 938.51 |
Gland Pharma | 2372.95 | 112.85 | 4.99 | 772.86 |
Lupin | 1093.15 | -12.55 | -1.14 | 727.55 |
Ipca Labs. | 2111.40 | -36.90 | -1.72 | 652.46 |
Abbott India | 14997.50 | -13.45 | -0.09 | 592.93 |
Fortis Health. | 166.00 | -5.65 | -3.29 | 513.33 |
Pfizer | 5113.80 | -44.30 | -0.86 | 509.13 |
Natco Pharma | 917.05 | -20.25 | -2.16 | 474.50 |
Apollo Hospitals | 2591.55 | 80.70 | 3.21 | 470.30 |
Granules India | 355.95 | -10.10 | -2.76 | 444.07 |
Ajanta Pharma | 1746.95 | -18.95 | -1.07 | 441.13 |
Quick Links for TTK Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices